Figure 2.
Relative abundance of SARS-CoV-2 BA.2.86 and other circulating variant groups in samples collected from COVID-19 cases in 19 of 21 regions, Sweden, weeks 31–38 2023 (n = 2,529 samples)
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2.
The total number (n) of samples from individuals analysed in weeks 31–38 is indicated for each region.